ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹3,959 Cr | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr | ₹3,604 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹3,959 Cr |
| Mar2024 | ₹3,995 Cr |
| Mar2023 | ₹3,707 Cr |
| Mar2022 | ₹4,805 Cr |
| Mar2021 | ₹3,604 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,959 Cr | -0.90 | |
| Mar2024 | ₹3,995 Cr | 7.75 | |
| Mar2023 | ₹3,707 Cr | -22.85 | |
| Mar2022 | ₹4,805 Cr | 33.33 | |
| Mar2021 | ₹3,604 Cr | - | |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,675.8 Cr | -1.1% | -8.9% | 5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -1.1% |
-8.9% |
5.6% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses